[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[2]
|
Hsieh, J.J., Purdue, M.P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., et al. (2017) Renal Cell Carcinoma. Nature Reviews Disease Primers, 3, Article No. 17009. https://doi.org/10.1038/nrdp.2017.9
|
[3]
|
Diaz-Montero, C.M., Rini, B.I. and Finke, J.H. (2020) The Immunology of Renal Cell Carcinoma. Nature Reviews Nephrology, 16, 721-735. https://doi.org/10.1038/s41581-020-0316-3
|
[4]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[5]
|
Panvichian, R., Tantiwetrueangdet, A., Angkathunyakul, N. and Leelaudomlipi, S. (2015) Top2a Amplification and Overexpression in hepatocellular Carcinoma Tissues. BioMed Research International, 2015, Article ID: 381602.
https://doi.org/10.1155/2015/381602
|
[6]
|
Wang, J.C. (2002) Cellular Roles of DNA Topoisomerases: A Molecular Perspective. Nature Reviews Molecular Cell Biology, 3, 430-440. https://doi.org/10.1038/nrm831
|
[7]
|
Morimoto, S., Tsuda, M., Bunch, H., Sasanuma, H., Austin, C. and Takeda, S. (2019) Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA. Genes, 10, Article No. 868.
https://doi.org/10.3390/genes10110868
|
[8]
|
Chen, T., Sun, Y., Ji, P., Kopetz, S. and Zhang, W. (2015) Topoisomerase IIalpha in Chromosome Instability and Personalized Cancer Therapy. Oncogene, 34, 4019-4031. https://doi.org/10.1038/onc.2014.332
|
[9]
|
Heestand, G.M., Schwaederle, M., Gatalica, Z., Arguello, D. and Kurzrock, R. (2017) Topoisomerase Expression and Amplification in Solid Tumours: Analysis of 24,262 Patients. European Journal of Cancer, 83, 80-87.
https://doi.org/10.1016/j.ejca.2017.06.019
|
[10]
|
Kou, F., Sun, H., Wu, L., Li, B., Zhang, B., Wang, X., et al. (2020) TOP2A Promotes Lung Adenocarcinoma Cells’ Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma. Journal of Cancer, 11, 2496-2508.
https://doi.org/10.7150/jca.41415
|
[11]
|
Hooks, K.B., Audoux, J., Fazli, H., Lesjean, S., Ernault, T., Dugot-Senant, N., et al. (2018) New Insights into Diagnosis and Therapeutic Options for Proliferative Hepatoblastoma. Hepatology, 68, 89-102.
https://doi.org/10.1002/hep.29672
|
[12]
|
Ogino, M., Fujii, T., Nakazawa, Y., Higuchi, T., Koibuchi, Y., Oyama, T., et al. (2020) Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients with Breast Cancer. In Vivo, 34, 3483-3487.
https://doi.org/10.21873/invivo.12188
|
[13]
|
Zhang, R., Xu, J., Zhao, J. and Bai, J.H. (2018) Proliferation and Invasion of Colon Cancer Cells Are Suppressed by Knockdown of TOP2A. Journal of Cellular Biochemistry, 119, 7256-7263. https://doi.org/10.1002/jcb.26916
|
[14]
|
Tang, Z., Li, C., Kang, B., Gao, G., Li, C. and Zhang, Z. (2017) GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses. Nucleic Acids Research, 45, W98-W102.
https://doi.org/10.1093/nar/gkx247
|
[15]
|
Chandrashekar, D.S., Bashel, B., Balasubramanya, S., Creighton, C.J., Ponce-Rodriguez, I., Chakravarthi, B.V.S.K., et al. (2017) UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia, 19, 649-658. https://doi.org/10.1016/j.neo.2017.05.002
|
[16]
|
Thul, P.J. and Lindskog, C. (2018) The Human Protein Atlas: A Spatial Map of the Human Proteome. Protein Science, 27, 233-244. https://doi.org/10.1002/pro.3307
|
[17]
|
Nagy, A., Lanczky, A., Menyhart, O. and Győrffy, B. (2018) Validation of miRNA Prognostic Power in Hepatocellular Carcinoma Using Expression Data of Independent Datasets. Scientific Reports, 8, Article No. 11515.
https://doi.org/10.1038/s41598-018-29514-3
|
[18]
|
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J.S., et al. (2017) TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Research, 77, e108-e110.
https://doi.org/10.1158/0008-5472.CAN-17-0307
|
[19]
|
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., et al. (2015) STRING v10: Protein-Protein Interaction Networks, Integrated over the Tree of Life. Nucleic Acids Research, 43, D447-D452.
https://doi.org/10.1093/nar/gku1003
|
[20]
|
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A.H., Tanaseichuk, O., et al. (2019) Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications, 10, Article No. 1523. https://doi.org/10.1038/s41467-019-09234-6
|
[21]
|
Lou, N., Ruan, A.M., Qiu, B., Bao, L., Xu, Y.C., Zhao, Y., et al. (2017) miR-144-3p as a Novel Plasma Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma. Urologic Oncology, 35, 36.e7-36.e14.
https://doi.org/10.1016/j.urolonc.2016.07.012
|
[22]
|
Wang, J., Yang, H., Si, Y., Hu, D., Yu, Y., Zhang, Y., et al. (2017) Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1. Cellular Physiology and Biochemistry, 43, 1325-1336.
https://doi.org/10.1159/000481844
|
[23]
|
Turley, H., Comley, M., Houlbrook, S., Nozaki, N., Kikuchi, A., Hickson, I.D., et al. (1997) The Distribution and Expression of the Two Isoforms of DNA Topoisomerase II in Normal and Neoplastic Human Tissues. British Journal of Cancer, 75, 1340-1346. https://doi.org/10.1038/bjc.1997.227
|
[24]
|
Romero, A., Martin, M., Cheang, M.C., López García-Asenjo, J.A., Oliva, B., He, X., et al. (2011) Assessment of Topoisomerase II Alpha Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization. American Journal of Pathology, 178, 1453-1460.
https://doi.org/10.1016/j.ajpath.2010.12.042
|
[25]
|
de Resende, M.F., Vieira, S., Chinen, L.T., Chiappelli, F., da Fonseca, F.P., Guimarães, G.C., et al. (2013) Prognostication of Prostate Cancer Based on TOP2A Protein and Gene Assessment: TOP2A in Prostate Cancer. Journal of Translational Medicine, 11, Article No. 36. https://doi.org/10.1186/1479-5876-11-36
|
[26]
|
Cao, Y., Zhang, G., Wang, P., Zhou, J., Gan, W., Song, Y., et al. (2017) Clinical Significance of UGT1A1 Polymorphism and Expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in Gastric Cancer. BMC Gastroenterology, 17, Article No. 2. https://doi.org/10.1186/s12876-016-0561-x
|
[27]
|
Gong, M.C., Chen, W.Q., Jin, Z.Q., Lyu, J., Meng, L., Wu, H., et al. (2021) Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer. International Journal of General Medicine, 14, 3485-3496. https://doi.org/10.2147/IJGM.S316145
|
[28]
|
Neganova, I., Tilgner, K., Buskin, A., Paraskevopoulou, I., Atkinson, S.P., Peberdy, D., et al. (2014) CDK1 Plays an Important Role in the Maintenance of Pluripotency and Genomic Stability in Human Pluripotent Stem Cells. Cell Death & Disease, 5, Article ID: e1508. https://doi.org/10.1038/cddis.2014.464
|
[29]
|
Heo, J., Noh, B.J., Lee, S., Lee, H.Y., Kim, Y.H., Lim, J., et al. (2020) Phosphorylation of TFCP2L1 by CDK1 Is Required for Stem Cell Pluripotency and Bladder Carcinogenesis. EMBO Molecular Medicine, 12, Article ID: e10880.
https://doi.org/10.15252/emmm.201910880
|
[30]
|
Pan, X.W., Chen, L., Hong, Y., Xu, D.F., Liu, X., Li, L., et al. (2016) EIF3D Silencing Suppresses Renal Cell Carcinoma Tumorigenesis via Inducing G2/M Arrest through Downregulation of Cyclin B1/CDK1 Signaling. International Journal of Oncology, 48, 2580-2590. https://doi.org/10.3892/ijo.2016.3459
|